|
|
|
|
|
• The FNAB is focused on translational research that could help developping individualized therapeutics
• Proposed research must include use of human tissue and have implications for therapeutic application and individualized medicine.
• Candidates must submit an abstract that involves use of human tissue and reflect the required focus on individualized medicine and therapeutic applications in human patients for presentation at the EORTC-NCI-AACR International Conference on Molecular Targets and Cancer Therapeutics when this conference is held in Europe (during even-numbered years), in addition to their Fellows Grant application.
• Candidates must have their abstract accepted for presentation at the EORTC meeting, and normally, this abstract must be selected for oral presentation by the Scientific Committee or other committee appointed to review such abstracts.
• Translational cancer research proposals focusing on individualized therapeutic area will be required from candidate to this grant. Selection of the awardee will be made by an independent scientific committee appointed by EORTC-NCI-AACR with participation of at least one member of FNAB Scientific Board
• The Fellows Grant consists of a yearly grant of 30,000 Euros renewable for a maximum of two years.
Please submit your abstracts to http://www.fecs.be/conferences/ena2004/abstractproffered.shtml